Once‐Daily Versus Twice‐Daily Vigabatrin: Is There a Difference? The Results of a Double‐Blind Pilot Study

This clinical study provides support for the pharmacological evidence that this preparation may be administered on a once or twice daily basis, depending on the individual patient's preference, total dosage and co-medication.